DRTS$14.033.62%0.49
After Hours: 14.05+0.02 +0.14%
Alpha Tau Medical Ltd (DRTS)
Date: 2026-11-04 16:00O: 13.85H: 14.20L: 13.59C: 14.03Vol: 685.9k
Alpha Tau Medical Ltd stock is traded at $14.03, with a volume of 685,890. It is up +3.62% in the last 24 hours and down -5.01% over the past month. Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Previous Close:
$13.54
Open:
$13.85
24h Volume:
685,890
Relative Volume:
1.54
Market Cap:
$1.30B
Revenue:
-
Net Income/Loss:
-$56.88M
P/E Ratio:
-
EPS:
-$0.6604
Net Cash Flow:
-$39.43M
1W Performance:
+5.09%
1M Performance:
-5.01%
6M Performance:
+86.32%
1Y Performance:
+262.53%
1-Day Range:
$13.59$14.20
1-Week Range:
$12.67$14.20
52-Week Range:
$3.43$15.79
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Alpha Tau Medical Ltd Stock (DRTS) Insider Trading
- Levy RaphiAug 21 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $15.00
- #Shares
- 2,871
- Value ($)
- 43,073
- #Shares Total
- 90,180
- Raphael (Raphi) Aryeh LevyAug 21 '26Officer
- Transaction
- Proposed Sale
- Cost
- $14.36
- #Shares
- 5,000
- Value ($)
- 71,800
- #Shares Total
- 0
- Levy RaphiAug 21 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $2.98
- #Shares
- 2,871
- Value ($)
- 8,556
- #Shares Total
- 93,051
- Levy RaphiAug 11 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $14.00
- #Shares
- 17,730
- Value ($)
- 248,277
- #Shares Total
- 90,180
- Levy RaphiAug 11 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $2.98
- #Shares
- 17,730
- Value ($)
- 52,835
- #Shares Total
- 107,910
- Levy RaphiJul 06 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $14.00
- #Shares
- 2,270
- Value ($)
- 31,782
- #Shares Total
- 90,180
- Levy RaphiJul 06 '26Officer
- Transaction
- Proposed Sale
- Cost
- $13.23
- #Shares
- 20,000
- Value ($)
- 264,600
- #Shares Total
- 0
- Levy RaphiJul 06 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $2.98
- #Shares
- 2,270
- Value ($)
- 6,765
- #Shares Total
- 92,450
- Levy RaphiJul 02 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $13.00
- #Shares
- 17,873
- Value ($)
- 232,397
- #Shares Total
- 90,180
- Levy RaphiJul 02 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $2.98
- #Shares
- 17,873
- Value ($)
- 53,262
- #Shares Total
- 108,053
